We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-0.39%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$579M
AUM Growth
+$10.3M
Cap. Flow
+$40.5M
Cap. Flow %
7%
Top 10 Hldgs %
80.36%
Holding
86
New
13
Increased
9
Reduced
4
Closed
5
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23.8M
2
COCH icon
Envoy Medical
COCH
+$4.26M
3
ROC icon
Rank One Computing Corp
ROC
+$3.19M
4
CRIS icon
Curis
CRIS
+$2.48M
5
VENU icon
Venu Holding Corp
VENU
+$2.31M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.13M
2
OWLT icon
Owlet
OWLT
+$1.46M
3
RHLD icon
Resolute Holdings Management
RHLD
+$1.04M
4
GPCR icon
Structure Therapeutics
GPCR
+$696K
5
LWLG icon
Lightwave Logic
LWLG
+$538K

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.59%
2 Industrials 23.83%
3 Healthcare 13.54%
4 Materials 5.99%
5 Technology 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$204M 35.33%
475,000
– –
2019 Q4
25 quarters
GPGI icon
2
GPGI Inc
GPGI
$3.59B
$67.9M 11.73%
3,969,676
-5,000
-0.1% -$108K
2022 Q1
16 quarters
RHLD icon
3
Resolute Holdings Management
RHLD
$897M
$51M 8.81%
314,166
-5,678
-2% -$1.04M
2025 Q1
4 quarters
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$44M 7.6%
67,645
+35,075
+108% +$23.8M
2023 Q4
9 quarters
LIN icon
5
Linde
LIN
$229B
$33.9M 5.87%
68,474
-6,640
-9% -$3.13M
2019 Q4
25 quarters
MDXH icon
6
MDxHealth
MDXH
$58.1M
$17M 2.93%
7,378,333
– –
2021 Q4
17 quarters
IDN icon
7
Intellicheck
IDN
$45.6M
$14.5M 2.51%
2,073,583
– –
2019 Q4
25 quarters
DUOT icon
8
Duos Technologies
DUOT
$167M
$11.2M 1.93%
1,627,806
– –
2020 Q1
24 quarters
INVE icon
9
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$10.7M 1.84%
2,884,495
– –
2019 Q4
25 quarters
BX icon
10
Blackstone
BX
$84.6B
$10.4M 1.8%
90,750
– –
2019 Q4
25 quarters
DTIL icon
11
Precision BioSciences
DTIL
$168M
$9.14M 1.58%
1,662,500
– –
2025 Q1
4 quarters
IMMX icon
12
Immix Biopharma
IMMX
$727M
$9.11M 1.57%
1,000,000
– –
2024 Q1
8 quarters
SPGI icon
13
S&P Global
SPGI
$123B
$8.51M 1.47%
20,000
– –
2019 Q4
25 quarters
LIQT icon
14
LiqTech
LIQT
$11.9M
$6.08M 1.05%
3,182,239
– –
2020 Q1
24 quarters
FLNT icon
15
Fluent
FLNT
$82.2M
$4.51M 0.78%
1,428,571
– –
2025 Q3
2 quarters
JPM icon
16
JPMorgan Chase
JPM
$887B
$4.41M 0.76%
15,000
– –
2019 Q4
25 quarters
COCH icon
17
Envoy Medical
COCH
$48.2M
$4.16M 0.72%
+6,250,000
New +$4.26M
2026 Q1
0 quarters
EYPT icon
18
EyePoint Inc
EYPT
$270M
$4.08M 0.71%
316,515
– –
2025 Q2
3 quarters
WELL icon
19
Welltower
WELL
$169B
$3.95M 0.68%
20,000
– –
2025 Q2
3 quarters
BRFH icon
20
Barfresh Food Group
BRFH
$11M
$3.91M 0.68%
1,390,758
– –
2022 Q1
16 quarters
PROK icon
21
ProKidney
PROK
$307M
$3.58M 0.62%
2,000,000
– –
2022 Q3
14 quarters
ROC icon
22
Rank One Computing Corp
ROC
$72.5M
$3.5M 0.6%
+500,000
New +$3.19M
2026 Q1
0 quarters
IRD icon
23
Opus Genetics
IRD
$354M
$3.35M 0.58%
736,842
– –
2025 Q1
4 quarters
GNLX icon
24
Genelux
GNLX
$110M
$3.34M 0.58%
1,380,666
+666,666
+93% +$1.82M
2025 Q1
4 quarters
NMTC icon
25
NeuroOne Medical Technologies
NMTC
$9.65M
$3.11M 0.54%
666,667
– –
2025 Q2
3 quarters
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2026 Portfolio in Review

As of Q1 2026, Bleichroeder LP held 86 positions worth $579M, up 1.8% from $568M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Bleichroeder LP deployed $40.5M of net new capital in Q1 2026, opening 13 new positions and adding to 9 existing holdings. Its largest new stake was Envoy Medical: 6,250,000 shares worth $4.16M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 38% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Linde, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q1 2026 buy was Envoy Medical: 6,250,000 shares worth $4.16M.
  • Bleichroeder LP added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $23.8M increase.
  • Bleichroeder LP's biggest Q1 2026 reduction was Linde, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Structure Therapeutics in Q1 2026, selling an estimated $696K.
  • Bleichroeder LP's ten largest holdings make up 80% of its $579M portfolio in Q1 2026.
  • Bleichroeder LP opened 13 new positions and closed 5 in Q1 2026.
  • Bleichroeder LP's portfolio value rose 1.8% quarter-over-quarter to $579M.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.